Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01020022 CE(15:1) cPLA2i 1.0 BCD110605C28 0.145 pmol/sample
LMST01020022 CE(15:1) cPLA2i 1.0 BCD110605C30 0.079 pmol/sample
LMST01020022 CE(15:1) cPLA2i 1.0 BCD110605C29 0.123 pmol/sample
LMST01020022 CE(15:1) cPLA2i 20.0 BCD110605C64 1.05 pmol/sample
LMST01020022 CE(15:1) cPLA2i 20.0 BCD110605C66 0.042 pmol/sample
LMST01020022 CE(15:1) cPLA2i 20.0 BCD110605C65 0.188 pmol/sample
LMST01020022 CE(15:1) PLDi 1.0 BCD110605C16 0.323 pmol/sample
LMST01020022 CE(15:1) PLDi 1.0 BCD110605C17 0.281 pmol/sample
LMST01020022 CE(15:1) PLDi 1.0 BCD110605C18 0.094 pmol/sample
LMST01020022 CE(15:1) PLDi 20.0 BCD110605C54 0.048 pmol/sample
LMST01020022 CE(15:1) PLDi 20.0 BCD110605C52 0 pmol/sample
LMST01020022 CE(15:1) PLDi 20.0 BCD110605C53 0.026 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 1.0 BCD110605C32 0.078 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 1.0 BCD110605C31 0 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 1.0 BCD110605C33 0.041 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 20.0 BCD110605C68 0.107 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 20.0 BCD110605C69 0.215 pmol/sample
LMST01020022 CE(15:1) KDO+cPLA2i 20.0 BCD110605C67 0.127 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 1.0 BCD110605C19 0.199 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 1.0 BCD110605C20 0.069 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 1.0 BCD110605C21 0.052 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 20.0 BCD110605C56 0 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 20.0 BCD110605C57 0.06 pmol/sample
LMST01020022 CE(15:1) KDO+PLDi 20.0 BCD110605C55 0 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 1.0 BCD110605C37 0.168 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 1.0 BCD110605C38 0.195 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 1.0 BCD110605C39 0.049 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 20.0 BCD110605C74 0.082 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 20.0 BCD110605C75 0.047 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+cPLA2i 20.0 BCD110605C73 0 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 1.0 BCD110605C25 0.079 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 1.0 BCD110605C27 0.123 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 1.0 BCD110605C26 0.151 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 20.0 BCD110605C61 0.171 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 20.0 BCD110605C62 0.148 pmol/sample
LMST01020022 CE(15:1) KDO+ATP+PLDi 20.0 BCD110605C63 0 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 1.0 BCD110605C15 0.106 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 1.0 BCD110605C14 0.067 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 1.0 BCD110605C13 0 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 20.0 BCD110605C49 0.113 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 20.0 BCD110605C50 0.057 pmol/sample
LMST01020022 CE(15:1) KDO + ATP 20.0 BCD110605C51 0.09 pmol/sample
LMST01020022 CE(15:1) KDO 1.0 BCD110605C08 0.163 pmol/sample
LMST01020022 CE(15:1) KDO 1.0 BCD110605C07 0.519 pmol/sample
LMST01020022 CE(15:1) KDO 1.0 BCD110605C09 0.06 pmol/sample
LMST01020022 CE(15:1) KDO 20.0 BCD110605C45 0 pmol/sample
LMST01020022 CE(15:1) KDO 20.0 BCD110605C44 0.156 pmol/sample
LMST01020022 CE(15:1) KDO 20.0 BCD110605C43 0.183 pmol/sample
LMST01020022 CE(15:1) C 0.0 BCD110605C03 0.075 pmol/sample
LMST01020022 CE(15:1) C 0.0 BCD110605C01 0.352 pmol/sample